Senator Collins' Statement on FDA Decision to Grant Full Approval of Alzheimer's Drug

July 7, 2023• by

Senator Collins’ Statement on FDA Decision to Grant Full Approval of Alzheimer’s Drug. Washington, D.C.— Today, U.S. Senator Susan Collins (R-ME), …

Full story here.

More Sen. Collins News

Published by www.collins.senate.gov

Visited 1 times, 1 visit(s) today

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Close Search Window
↑
Designed by Dannci